In late 2011, the University of Utah Health system saw several major advancements in medical technology and research funding. Notable developments included the first human use of a Utah-developed bloodless scalpel and the receipt of multi-million dollar grants for genetic research.
Surgeons at the University of Utah's Clinical Neurosciences Center utilized a novel tool known as a bloodless scalpel for the first time. Developed in Utah, the device was designed to cut and cauterize simultaneously, with the potential to provide more precise cutting, fewer complications, and shorter healing times for patients.
In terms of research funding, University of Utah investigators were awarded a $2.96 million grant to explore the genetic causes of Down syndrome. This study, which included Utah families, aimed to provide insights into the human brain and potential treatment strategies for mental disability.
The University of Utah College of Nursing received high-level accreditation for its BS and MS programs, while also receiving accreditation for a new DNP program. Additionally, the pharmacy residency program at University of Utah Hospitals and Clinics was recognized with the ASHP Program Award for excellence in training.
Other notable medical news from the period included the expansion of the Deep Brain Stimulation Program with new Medical and Surgical Directors appointed to improve care for movement disorders. Furthermore, the TRAILS program at the University of Utah Health Care Rehabilitation Center partnered with the U.S. Paralympics to create a local chapter of Paralympic Sport - Salt Lake City.
The period was also marked by various individual recognitions, such as Dr. Andrew S. Weyrich receiving international recognition for work in thrombosis and haemostasis, and four faculty members from the Department of Biomedical Informatics receiving national honors.
